Editorial: GLP-1 receptor agonists in inflammatory bowel disease-Is it time?

被引：0
|
作者：
Arvanitakis, Konstantinos [1 ,2 ]
Germanidis, Georgios [1 ,2 ]
机构：
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Internal Med 1, Div Gastroenterol & Hepatol, St Kiriakidi 1, Thessaloniki 54636, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Basic & Translat Res Unit, Special Unit Biomed Res & Educ,Fac Hlth Sci, Thessaloniki, Greece
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 05期
关键词：
D O I：
10.1111/apt.18152
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Desai et al papers. To view this article, visit
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [31] Editorial: older-onset inflammatory bowel disease-is it time to start looking beyond a number?
    Taleban, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (07) : 1034 - 1035
  • [32] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [33] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
  • [34] INVESTIGATION OF POTENTIAL ANTI-INFLAMMATORY AND ANTIFIBROTIC EFFECTS OF GLP-1 RECEPTOR AGONISTS
    Gorman, D. M.
    Nolan, E.
    Gaffney, A.
    Godson, C.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S493 - S493
  • [35] Falsified versions of GLP-1 receptor agonists reported
    Reactions Weekly, 2023, 1974 (1) : 3 - 3
  • [36] Diabetic ketoacidosis with GLP-1 receptor agonists, insulin
    Reactions Weekly, 2019, 1760 (1) : 1 - 1
  • [37] GLP-1 receptor agonists and the risk of colorectal cancer
    Kakkar, Ashish Kumar
    MEDICAL HYPOTHESES, 2014, 82 (06) : 796 - 796
  • [38] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [39] Appendicitis: A Hidden Danger of GLP-1 Receptor Agonists?
    Casella, Sarah
    Galli, Katelyn
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (02) : 108 - 111
  • [40] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Zhao, Xin
    Wang, Minghe
    Wen, Zhitong
    Lu, Zhihong
    Cui, Lijuan
    Fu, Chao
    Xue, Huan
    Liu, Yunfeng
    Zhang, Yi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345